Exenatide
Exenatide (pronunciation: /ɛksɛˈnætaɪd/) is a medication used to treat Type 2 diabetes. It is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) also referred to as incretin mimetics.
Etymology
The term "Exenatide" is derived from the species name of the Gila monster, Heloderma suspectum, from which the active ingredient of the drug was originally isolated.
Usage
Exenatide is used along with diet and exercise to improve blood sugar control in adults with type 2 diabetes. It is not recommended for people with type 1 diabetes or for the treatment of diabetic ketoacidosis.
Mechanism of Action
Exenatide enhances glucose-dependent insulin secretion by the pancreatic beta-cell, suppresses inappropriately elevated glucagon secretion, and slows gastric emptying.
Side Effects
Common side effects of Exenatide include nausea, vomiting, diarrhea, feeling jittery, and acid stomach. Serious side effects may include kidney problems, pancreatitis, and low blood sugar.
Related Terms
- Type 2 diabetes
- Glucagon-like peptide-1 receptor agonist
- Incretin mimetics
- Pancreatic beta-cell
- Glucagon
- Gastric emptying
- Kidney problems
- Pancreatitis
- Low blood sugar
External links
- Medical encyclopedia article on Exenatide
- Wikipedia's article - Exenatide
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski